Collin Anderson

Collin Anderson is a Lecturer at the University of Sydney, affiliated with the School of Medical Sciences (Faculty of Medicine and Health) and the School of Biomedical Engineering (Faculty of Engineering). His research focuses on neurosciences and biomedical engineering, with a particular emphasis on movement disorders, Parkinson's disease, and nervous system diseases. He is a member of The Centre for Drug Discovery Innovation and has been awarded the Drug Discovery Initiative Early Career Researcher Award.

• Education – Not explicitly listed in the profile.

His research interests include gene therapy for neurological disorders, neurostimulation techniques (e.g., deep brain stimulation), and translational approaches to movement disorder treatment. Recent work involves viral vector-based therapies for Christianson syndrome and computational models to optimize neural stimulation parameters.

Publications span topics like dopamine receptor modulation in tic disorders, allopregnanolone’s role in stress response, and cerebellar stimulation for ataxia. His work bridges basic neuroscience, engineering, and clinical applications.

• Key Awards: Drug Discovery Initiative Early Career Researcher Award (3-10 Years Post PhD).

Collin supervises research students like Kajal DAHIYA on preclinical gene therapy studies. His grants include funding for Christianson syndrome research and neural stimulation optimization from the RTW Charitable Foundation and Faculty of Medicine and Health.

He collaborates with interdisciplinary teams, leveraging tools like EEG sequence learning for comatose patient prognosis and deep learning for rodent motor impairment analysis.